National Health Act 1953 Amendment determination under subsections 85AB(1) and 85AC(1) drugs on F1 and drugs in Part A of F2 (No. PB 70 of 2010) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 70 of 2010
Amendment determination under subsections 85AB(1) and 85AC(1) of the National Health Act 1953
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 85AB(1) and 85AC(1) of the National Health Act 1953.
Dated 5 JULY 2010
DIANA MACDONELL
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment Determination – drugs on F1 and drugs in Part A of F2
1. Commencement
This instrument commences on 1 August 2010.
2. Amendment of PB 95 of 2007
Schedule 1 amends PB 95 of 2007.
Schedule 1 Amendments
[1] Paragraph 2, Drugs on F1, after “Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements with phenylalanine and tyrosine and supplemented with docosahexanoic acid”,
insert:
“Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without methionine and supplemented with docosahexanoic acid”,
[2] Paragraph 2, Drugs on F1, after “Arsenic”,
insert:
“Certolizumab pegol”,
[3] Paragraph 2, Drugs on F1, after “Essential amino acids formula”,
insert:
“Exenatide”, “Ganirelix”, “Golimumab”,
[4] Paragraph 2, Drugs on F1, after “Telbivudine”,
insert:
“Tocilizumab”, “Vildagliptin”,
[5] Paragraph 3, Drugs on F2, after “Fludarabine”,
insert:
“Galantamine”,
[6] Paragraph 3, Drugs on F2, after “Sodium lactate compound”,
insert:
“Sorbitol with sodium citrate and sodium lauryl sulfoacetate”,
[7] Paragraph 4, Drugs in Part A of F2, after “Fludarabine”,
insert:
“Galantamine”,
[8] Paragraph 4, Drugs in Part A of F2, after “Sodium lactate compound”,
insert:
“Sorbitol with sodium citrate and sodium lauryl sulfoacetate”,
0
0
0